ATLASATLAS fair value
ATLAS has no fair value for this stock today.
OrganiGram (OGI.TO)
OrganiGram stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Toronto Stock Exchange · Canada
CA$1.32▲ +0.76%
Prices as of Oct 27, 2026 · CAD
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on OrganiGram in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On OrganiGram
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives OrganiGram a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CA$1.18 and CA$1.45; in 9 out of 10, between CA$0.992 and CA$1.73. Estimated annual volatility is 56%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CA$183M
- Market cap (USD)
- $130M
- P/E ratio
- 2.2
- 52-week high
- CA$3.09
- 52-week low
- CA$1.20
- Revenue (12 months)
- CA$309M
- Gross margin
- 36.5%
- Operating margin
- 5.0%
- Net margin
- 28.0%
- Beta
- 1.91
What this means
ATLAS does not publish a fair value for OGI.TO right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks OGI.TO has traded between CA$1.20 and CA$3.09. Today it is 57.3% below that high and 10% above its low.
On the business: net margin is 28.0%; it trades at 2.2 times earnings.
Its beta is 1.91: it tends to move more than the market, both up and down.
About the company
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada.
Want to see everything about OrganiGram?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does OrganiGram do?
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada.
What is the chance OGI.TO goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, OGI.TO ends the month between CA$1.18 and CA$1.45.
How big is OrganiGram and what is its P/E ratio?
OrganiGram's market capitalization is CA$183M. Its price-to-earnings (P/E) ratio is 2.2: you pay CA$2.20 for each CA$1.00 of yearly earnings.
How volatile is OGI.TO?
ATLAS estimates annual volatility at 56%. In a typical month, half of the outcomes end between CA$1.18 and CA$1.45.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer